Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LQDA | LIQUIDIA CORP | $56.60 | $17.69 | 219.92% | 235.83x | 20.93x | 17.29x | 46.36x | 1.19x | $41.15M | 0.83% | $108.58M | 1.23 | $4.99B | 93.19 | ||
| SLNO | SOLENO THERAPEUTICS INC | $52.93 | $61.06 | -13.32% | 28.61x | 13.14x | 9.67x | 5.56x | 0.36x | $105.42M | 3.82% | $495.80M | 9.52 | $2.68B | 24.91 | ||
| CORT | CORCEPT THERAPEUTICS INC | $51.16 | $16.28 | 214.18% | 111.22x | 94.29x | 6.95x | 8.61x | 1.28x | $119.79M | 2.24% | $637.99M | 6.11 | $5.39B | -785.47 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $292.03 | $99.14 | 194.55% | 66.98x | 41.19x | 9.05x | 36.26x | 1.33x | $641.34M | 1.65% | $1.08B | 8.09 | $40.25B | 43.54 | ||
| ADMA | ADMA BIOLOGICS INC | $8.41 | $11.83 | -28.89% | 12.19x | 8.47x | 3.89x | 4.99x | 0.36x | $107.90M | 5.43% | $390.33M | 1.65 | $2.01B | 9.07 | ||
| ASND | ASCENDIS PHARMA A | $237.65 | $104.35 | 127.74% | 25.19x | 55.71x | 14.49x | 25.71x | 1.53x | $52.94M | 0.36% | $574.09M | 9.24 | $15.14B | 162.37 | ||
| KRYS | KRYSTAL BIOTECH INC | $310.31 | $103.12 | 200.93% | 40.04x | 39.47x | 21.78x | 7.17x | 1.74x | $237.38M | 2.61% | $1.28B | 43.59 | $8.66B | 40.45 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $11.05 | $16.46 | -32.86% | 5.39x | 22.29x | 5.28x | 3.17x | 0.71x | $56.42M | 8.74% | $205.80M | 3.52 | $558.77M | 3.86 | ||
| VCEL | VERICEL CORP | $32.94 | $8.82 | 273.40% | 76.60x | 74.24x | 5.73x | 4.72x | 1.74x | $47.49M | 2.84% | $356.23M | 7.02 | $1.67B | 41.25 | ||
| HALO | HALOZYME THERAPEUTICS INC | $70.93 | $72.11 | -1.63% | 23.96x | 8.60x | 5.56x | 38.31x | 0.44x | $667.65M | 7.97% | $219.64M | 1.86 | $10.25B | 16.42 | ||
| RPRX | ROYALTY PHARMA PLC | $51.70 | $42.45 | 21.79% | 27.07x | 9.77x | 9.25x | 3.00x | 0.55x | $2.34B | 10.37% | $9.94B | 22.75 | $38.14B | 32.78 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.85 | $3.05 | 26.38% | 16.04x | 14.11x | 2.36x | 3.72x | 0.76x | $4.11M | 1.32% | $82.33M | 1.03 | $242.66M | 11.42 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $6.26 | $2.88 | 117.43% | 89.43x | 52.38x | 3.39x | 83.06x | 0.86x | $47.52M | 4.46% | $13.01M | 0.08 | $1.23B | 22.97 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $59.48 | $16.29 | 265.20% | 60.69x | 53.92x | 6.04x | 7.56x | 1.86x | $164.23M | 3.61% | $605.69M | 7.92 | $4.40B | 39.43 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $52.88 | $42.00 | 25.89% | 37.77x | 11.70x | 3.14x | 1.65x | 0.53x | $767.06M | 7.54% | $6.21B | 32.27 | $8.58B | 17.78 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $227.84 | $49.51 | 360.18% | 484.77x | 9.36x | 3.18x | 3.15x | 1.67x | $1.30B | 9.20% | $4.53B | 73.22 | $17.85B | 26.45 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $30.15 | $35.88 | -15.96% | 11.92x | 8.45x | 1.94x | 1.92x | 0.47x | $341.79M | 19.61% | $910.35M | 15.75 | $1.31B | 5.55 | ||
| TECH | BIO-TECHNE CORP | $47.42 | $16.72 | 183.59% | 66.79x | 23.45x | 6.12x | 3.56x | 1.27x | $269.60M | 3.64% | $2.09B | 13.34 | $7.50B | 29.32 | ||
| SPRO | SPERO THERAPEUTICS INC | $2.54 | $4.91 | -48.31% | 16.93x | 3.72x | 2.13x | 2.49x | 0.21x | -$12.62M | -8.86% | $59.02M | 1.05 | $109.67M | 12.42 | ||
| UTHR | UNITED THERAPEUTICS CORP | $581.74 | $266.95 | 117.92% | 19.87x | 19.73x | 7.98x | 4.18x | 1.84x | $1.02B | 4.02% | $5.90B | 135.66 | $23.41B | 13.66 | ||
| EXEL | EXELIXIS INC | $49.46 | $31.57 | 56.66% | 15.85x | 15.76x | 5.38x | 6.42x | 1.16x | $917.69M | 7.18% | $1.94B | 7.49 | $12.38B | 11.72 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $31.14 | $14.63 | 112.92% | 17.20x | 15.08x | 6.38x | 3.76x | 2.21x | $208.13M | 5.47% | $1.01B | 8.28 | $3.06B | 9.13 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $222.00 | $82.81 | 168.10% | 28.10x | 24.07x | 16.08x | 4.46x | 1.90x | $122.22M | 2.77% | $997.32M | 50.16 | $4.79B | 21.22 | ||
| MDXG | MIMEDX GROUP INC | $3.54 | $1.81 | 96.02% | 16.86x | -260.29x | 1.35x | 2.17x | 1.81x | $69.36M | 13.19% | $242.94M | 1.64 | $385.09M | 7.07 | ||
| PBYI | PUMA BIOTECHNOLOGY INC | $7.08 | $4.40 | 61.01% | 14.16x | 17.35x | 1.58x | 2.81x | 1.44x | $53.60M | 14.89% | $128.42M | 2.53 | $338.04M | 7.51 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $723.41 | $440.07 | 64.39% | 17.00x | 15.35x | 5.04x | 2.41x | 1.18x | $4.11B | 5.47% | $31.42B | 302.15 | $75.59B | 13.16 | ||
| SRPT | SAREPTA THERAPEUTICS INC | $19.13 | $6.88 | 178.20% | 31.88x | 6.01x | 0.92x | 1.34x | 1.81x | $109.24M | 5.44% | $1.51B | 14.34 | $2.59B | 31.33 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $448.29 | $178.07 | 151.75% | 26.35x | 23.02x | 9.32x | 5.88x | 1.79x | $3.71B | 3.26% | $19.36B | 76.20 | $110.27B | 20.45 | ||
| INCY | INCYTE CORP | $99.13 | $68.22 | 45.30% | 13.60x | 12.65x | 3.69x | 3.52x | 1.18x | $1.45B | 7.34% | $5.62B | 28.21 | $16.38B | 8.75 | ||
| VCYT | VERACYTE INC | $39.56 | $9.10 | 334.79% | 35.64x | 43.25x | 5.81x | 2.35x | 4.39x | $155.34M | 4.94% | $1.34B | 16.90 | $2.93B | 25.48 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.